Your browser doesn't support javascript.
loading
Population pharmacokinetic-pharmacodynamic model-based exploration of alternative ustekinumab dosage regimens for patients with Crohn's disease.
Wang, Zhigang; Verstockt, Bram; Sabino, João; Vermeire, Séverine; Ferrante, Marc; Declerck, Paul; Dreesen, Erwin.
  • Wang Z; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Verstockt B; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
  • Sabino J; Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
  • Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
  • Ferrante M; Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
  • Declerck P; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
  • Dreesen E; Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Br J Clin Pharmacol ; 88(1): 323-335, 2022 01.
Article en En | MEDLINE | ID: mdl-34197653
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Ustekinumab Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Ustekinumab Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article